Two on it. Do you have any good suggestions? Xiao Zhen smiled faintly

Liu Mingquan and Zheng Denggao glanced at each other this time but the two did not speak immediately Obviously, for this. Questions, they also have to think about it, not because of how difficult this question is for them, but because they have to think about it, how to answer it to satisfy Xiao Shao.

Anyone can speak, but saying the same thing to different effects has always been an art.

"Xiao Shao's question is a bit big, we have limited knowledge, and we can only answer according to our ability, if it is not correct or not comprehensive, please Xiao Shao don't blame Liu Mingquan for setting an ambush first, as a buffer in case there is disharmony.

Xiao Zhen smiled: "It's okay to say it. ”

In fact, Xiao Zhen came to them today, in addition to asking these questions, he also introduced Su Ning to know them, so that Su Ning would have many things to do in the future. Although Xiao Zhen did not intend to make Tianxin Group a tool for the Xiao family's wealth, many industries now have some unspeakable rules, and with today's meeting, at least Su Ning will not be blinded by some blind people in some "procedures" in the future. Stuck on it.

As for the background of today's pharmaceutical industry, Xiao Ding knows most of the situation in the general direction, and more specific but not familiar with it, but Su Ning has specialized in this way over the years, and before he came, he also showed Xiao Zhen a report collected and evaluated by Tianxin Group. This report is still very desirable in Xiao Ke's opinion, which fully shows that Su Ning has indeed been very careful in managing Tianxin over the years. This report makes eight points of understanding of the current situation of the pharmaceutical industry, which is simply as follows:

The pharmaceutical industry is a special industry that is closely related to the national economy and people's livelihood and people's lives. General Secretary Jiang Enguo once pointed out: "Realizing that everyone in the country enjoys health care, continuously improving the people's health, and improving the quality of the whole nation is an important goal of economic and social development and spiritual civilization construction, and is an important symbol that the people's living standards have reached a well-off level, and is also an important guarantee for promoting economic development and social progress. It has the function of protecting productive forces and has an important position and role in the national economy.

2. The pharmaceutical industry is a key industry supported by China. It is an important part of China's national economy, and it is an industry that combines traditional industries and modern industries, with a long industrial chain and a high degree of relevance. In addition to medical and health care, the downstream industries of the pharmaceutical industry are currently penetrating into health food, equipment, sanitary products, cosmetics, environmental protection industry, green agriculture and other aspects. 3. The pharmaceutical industry is one of the international industries classified according to international standards. It is one of the fastest-growing categories of products in world trade. It has become one of the industries closely watched by countries around the world. The pharmaceutical industry is a typical international industry, with good exhibition prospects, and is a sunrise industry that will never decline. The pharmaceutical exhibition is closely related to people's health, living standards, and science and technology exhibitions. According to the forecast of the relevant departments, the elasticity coefficient of demand for social medical and health care commodities is that the people's living standards increase by one for every one. percentage points, the level of medical consumption should be increased, a percentage point. It shows that the growth rate of medical consumption level is significantly higher than the growth of residents' living standards.

4. The pharmaceutical industry is a high-input industry. The early stage of its product research and production process, the transformation of Peng, and the market development of the final product on the market are even, which contains a high degree of capital investment. In particular, new drug research is prescribed6. The process is costly, time-consuming, and difficult. For example, in the U.S. pharmaceutical industry, research funding has doubled every other year in the past few years. In the United States, the ratio of R&D expenses to sales in various industries is as follows: manufacturing industry accounts for concave, aerospace industry accounts for Zhang, electronics accounts for 8%, and computers account for 83%. The pharmaceutical industry accounts for the average of Zhang. It can be seen that the investment in drug research and development is much greater than that of other industries, and also much more than the whole. The average level of the industry. Due to the particularity of the production and use of drugs and medical devices, the investment in their marketing and use management and after-sales service systems is far greater than that of general industries.

The pharmaceutical industry is a high-tech industry. It incorporates advanced technologies and means from various disciplines. In particular, the rapid development of modern biological new techniques has injected new vitality into the take-off of the pharmaceutical industry. Electronic trading systems are widely used in pharmaceutical business, and online medical care is being popularized in Da countries. The latest scientific and technological achievements of mankind are always used in the first time by life sciences and closely related pharmaceutical industry and commerce.

6. The pharmaceutical industry is an industry that can create high added value.

Since 6. Once a pharmaceutical company obtains marketing approval for a new drug, it is natural that its high selling price will be high for high profits. In order to protect the interests of research and development enterprises. Pharmaceuticals are protected by patents. During the patent period, the drug enjoys market exclusivity, and the profit margin of the patented drug is significantly higher than that of the generic drug. Glaxo's anti-peptic ulcer drug ranitidine has sold tens of millions of dollars since it was launched, reaching a peak of $100 million in the highest year. During the patent period, the sales of the drug ranked in the world for ten consecutive years, and its profits were quite lucrative.

7. The pharmaceutical industry is a high-risk investment industry. The investment of new drugs is a series of costly systematic projects from synthesis and extraction, biological screening, pharmacology, toxicology and other preclinical trials, formulation and stability tests, bioavailability tests and scale-up tests until clinical trials for human use, registration and marketing and after-sales supervision. Generally speaking, it takes about 100 million US dollars to successfully prescribe a new drug in the era, and it takes about 100 million US dollars in the Qin era, which is worth trillions of dollars in the era and 380 billion US dollars in the era of Na. If one of these details goes wrong, there is a danger that it will fall short. Therefore, the success rate of new drug research and prescription is low, and the United States is the "edge". , Japan for the "hook...... Therefore, the introduction of new drugs has both high profit margins and high risks.

8. The pharmaceutical industry is a relatively decisive industry. In a sense, the pharmaceutical industry is monopolized by pharmaceutical companies based on research and development. The world's former pharmaceutical company Pengnian accounted for its sales of the world's total Bi, and the former Lijia company had a good edge. Some people expect that in the old years, the world's leading pharmaceutical companies will occupy the global drug sales. In recent years, mergers and acquisitions of pharmaceutical companies are a manifestation of capital concentration. The same is true for the pharmaceutical business. In Japan and other countries, there are only a few dozen pharmaceutical wholesalers, and most of them are occupied by a few large chain wholesalers and chain pharmacies.

In addition, the report also has a full understanding of the problems of the domestic pharmaceutical industry in Huaxia, and in their opinion, there are seven main problems and reasons for the current problems faced by the pharmaceutical industry in Huaxia.

Over the years, industrial and commercial enterprises have been "scattered, chaotic and poor." The situation is difficult to improve. Large group exhibitions have encountered obstacles in the market, the establishment of batch networks and retail chains has been plagued by local protection, and it is still difficult to register in the name and brand of large groups in the local area, making it difficult for enterprises to expand at a lower cost, and the long-term low-level repeated construction of the pharmaceutical industry has further deepened the negative impact.

2. Some pharmaceutical management departments, medical and health departments or medical institutions set up drug trading companies or set up pharmaceutical factories, and there is no separation between government and enterprises, and the administration interferes in the market, resulting in a situation of unequal competition.

3. Because of the instigation of some local governments or departments, the drug bazaar has been repeatedly banned, violating laws and disciplines, evading taxes, impacting the normal transaction order, and squeezing or plundering commercial profits.

4. If the relevant departments of the state only allow the industrial and commercial price difference to be maintained at the old level in terms of price regulations, traditional large-scale commercial enterprises are bound to bear high debts, a large number of retired workers and concave transformation costs, and participate in market competition, and the result will be contrary to the original intention of the price policymakers. ”

The per capita drug level in China is still lower than that of Western countries. As far as China is concerned, the gap between the per capita drug use level in urban areas and the per capita drug use level in rural areas is very significant. On the other hand, there is still a shortage of medical care and medicine in some rural areas, and the urban population, which basically accounts for the whole country, consumes the famous medicines, and the rural population only consumes the old medicines, and the structural contradiction in the consumption of medicines is prominent, and the problem of opening and supplying the rural medicine market needs to be solved.

6. Foreign-funded enterprises, especially multinational corporations and smuggled products, crowd out the Chinese pharmaceutical market. The pharmaceutical industry is an international industry, there are fewer barriers between the world, and China's pharmaceutical industry is also opening up to the outside world earlier, and the first Sino-foreign joint venture in the country was built in the early eighties. At present, the total number of joint ventures and cooperative enterprises of various types is about one. Imported products and products of multinational corporations have accounted for more than one market share in the country. Some products have been able to be produced and supplied in large quantities in China, and they have continued to import and compete with domestic products for the market, impacting the domestic market. The volume value of pharmaceutical products is high, and smuggling is difficult to block, which affects the national industry.

7. The internal mechanism of most traditional medicine commercial enterprises is outdated, the market control and market share are declining, and the system needs to be innovated.

The quality and efficiency of pharmaceutical economy, especially the operation of pharmaceutical business, are still low, which is directly related to the above negative impacts and the mutual impact between them.

With this report of Tianxin Group to give Xiao Zhen a foundation, he can make a more comprehensive evaluation and thinking about Liu Mingquan and Zheng Denggao's analysis suggestions, and listen to both the clear and the dark, which is Xiao Ke's consistent proposition.

Liu Mingquan saw that Xiao Zhen responded, so he nodded, and first analyzed: "I think that in the face of such a situation, we must first have a comprehensive understanding of the overall trend of the country's macroeconomic operation, pay attention to the process of global economic integration, in-depth study of the impact of various national supporting reform measures on pharmaceutical enterprises, take the initiative to adapt to various new changes in the macroeconomic situation, and adjust strategies in a timely manner, and gradually solve the deep-seated problems in the field of pharmaceutical production and circulation." Adjusting the economic structure of medicine and improving the quality and efficiency of pharmaceutical operation are the top priorities of improving the market control of enterprises, resisting risks, and establishing a modern enterprise system. As mentioned earlier, the intensity of strategic reorganization of state-owned enterprises continues to increase. The Fourth Plenary Session of the 15 th CPC Central Committee further emphasized that state-owned enterprises are the pillars of the national economy, and that the reform and development of state-owned enterprises have a bearing on the country's long-term peace and stability, the consolidation of the socialist system, and the future and destiny of China in the next century. The "Decision" systematically puts forward 10 important guidelines for the reform and development of state-owned enterprises, and on the basis of the goal of extricating state-owned enterprises from difficulties within three years, it also puts forward medium- and long-term goals, thus pointing out a clearer direction for the reform and development of state-owned enterprises. At the same time, in terms of policy, various measures have been put forward to improve the asset-liability structure of state-owned enterprises and to reduce social burdens, such as diversifying the equity of state-owned enterprises, implementing the practice of converting debts into equity, increasing the reserve for banks to write off bad debts, and stipulating that enterprises can discount interest for technological transformation. These new developments and breakthroughs are bound to have a major and far-reaching impact on promoting the reform of state-owned enterprises and on tackling tough problems and on the cross-century exhibition. Pharmaceutical companies are required to seize the opportunity, actively promote the alliance and reorganization between enterprises, and gradually change the situation of "many, scattered, chaotic and low" enterprise organization scale. The reform of the state-owned enterprise system is closely related to the operation of private enterprises, and if it is a large private pharmaceutical enterprise, such as a pharmaceutical giant such as Tianxin Pharmaceutical Group, I think we should strengthen the ties with the relevant central and local departments, and strive to get some convenience in policy, or at least there should be no constraints

Xiao Ke listened. He smiled slightly, nodded and said, "Director Liu is right, he hasn't said the second half of his sentence yet, if not, what am I doing with Su Ning to you?" The representative of the Ministry of Health, "the relevant departments of the central government. As for the relevant local departments, Su Ning's Tianxin Group is not a small business or a leather bag company, and she herself has been exercising in the position of the chairman of Tianxin Pharmaceutical Group for six or seven years, so she naturally has the ability to deal with this kind of thing.

Xiao Zhen smiled: "The problems in the political system are indeed something that must be paid attention to first. Therefore, the pharmaceutical industry has both the general social commodity attributes of "focusing on the pursuit of economic interests and being guided by market demand, and also has its different particularity, that is, it is a special commodity that pursues its economic benefits under the premise of paying attention to social benefits. Pharmaceutical commodities have their particularity, that is, their use value is extremely special, and their relationship is to life and health, so they must be carefully managed in accordance with the law to ensure their quality and ensure the safety and effectiveness of use. In particular, when preparing for war and preparing for the United States, emergency rescue and disaster relief, and coping with sudden accidents, the different and ordinary nature of this special commodity with the significance of national strategic materials is more prominent. Turning his head to look at Su Ning, he said, "Even private companies are no exception. ”

Su Ning nodded gently.

Xiao Zhen smiled at Liu Mingquan and said, "Director Liu, please continue." ”

Liu Mingquan laughed and said in a deep voice: "Second, we must rely on the system and scientific and technological innovation to speed up the property rights system" and establish a corporate governance structure with a diversified investment system. Break through the barriers that affect productivity. The organization of circulation should be changed, and the number of enterprises should be implemented as an agent distribution system, and retail enterprises should engage in a chain management system; Develop a new industrial and commercial cooperation model, speed up the construction of the network, and promote the formation of enterprises to form a general agent, general distribution of scale competitive advantage; Implement large-scale and intensive management, form core competitiveness, strengthen economic strength, reduce operating costs, expand market share, form strong competition, and make enterprises in the fierce market

Xiao Zhen nodded slightly, but Zheng Denggao next to him suddenly said: "Xiao Shao, when it comes to scientific and technological innovation, I will add one point." Since the Sino-US intellectual property talks, patents for pharmaceutical products have also been protected by law, and they cannot be produced without the consent of the patentee. China has also given administrative protection to some foreign patents. The state has formulated regulations on the protection of traditional Chinese medicine. The protection of intellectual property rights by these provisions is conducive to protecting the interests of intellectual property owners, encouraging people to create new ideas, and promoting the progress and prosperity of medical technology. After joining the WTO, the protection of pharmaceutical intellectual property rights is a prominent issue, which requires our attention and response

Xiao Zhen nodded and smiled: "Director Zheng has a point, this point is indeed worth noting. He noticed that Zheng Denggao used "we." "But Xiao Ding is not broken, the reason why he came to the two of them, in addition to the previous reason, is to support their leadership, Minister Huo, the executive deputy minister of the Ministry of Health, now has a close relationship with Uncle Xiao Zheng, and there is a faint possibility of becoming a member of the Xiao family, in this case, Minister Huo's right-hand man, it is naturally best to unite under the banner of the Xiao family, so Xiao Zhen will invite them so unabashedly today, this Director Zheng Denggao, is one. Smart people are worthy of being so smart that they are "thorough".

After Xiao Zhen finished speaking, he looked at Liu Mingquan again, and Liu Mingquan continued with a smile: "The third one is to take market demand as the guide and the national basic medical insurance drug catalog as the basis, and carefully organize the adjustment of the company's product management structure. It is necessary to seize the opportunities of the basic medical insurance system for urban workers, the reform of the medical and health system, and the classified management system of prescription drugs and non-prescription drugs, and determine the variety supply and marketing strategy according to the reallocation of health resources, according to the needs of different hospitals and different patients; It is necessary to aim at the position of the 100 million market, the rural market and the community health service. The development of healthy consumption is an important breakthrough in expanding domestic demand. Accelerate the opening of new markets, expand the network, and expand the scope of availability; Pay attention to the operation of domestic general drugs and new drugs, especially the introduction and market promotion of high-tech products, increase market share and coverage, and expand the space for economic growth of enterprises

After Liu Mingquan finished speaking this time, he looked directly at Zheng Denggao, Xiao Zhen saw it, so he also looked at Zheng Denggao, Zheng Denggao smiled, touched the top of his half-bald head, and said: "I agree with Lao Liu's opinion, in this regard, I think we must pay attention to the changes in population, age and disease spectrum and regional structure."

"The natural increase in population necessarily requires a correspondingly large market for more medical drugs and medical devices," he explains. Not only is the total population of our country increasing, but the demographic structure is also changing. On the one hand, the transformation of rural population to urban population has accelerated, and the level of drug use has increased; On the other hand, the aging of China's population is accelerating. It is predicted that by the end of the year, the population will be controlled at 100 million. Knife. Year to force cake. The number of elderly people aged and above in the West will increase by 10,000 per year, and the force will reach the end of the year. 100 million people. A little bit of our country. The number of elderly people over the age of 100 million has reached 100 million. The elderly over the age of age not only cost a lot of treatment, but also need anti-aging, and the total price of drugs consumed by them and children accounts for about 1% of the total consumption of the whole society. The increase in the proportion of the elderly population, the continuous implementation of the one-child policy, the improvement of people's living standards, the population flow caused by the development of the market economy and the acceleration of the urbanization process will cause changes in the disease spectrum and consumption habits, and non-communicable diseases will increase significantly. The top 10 major diseases in the country are malignant tumors, and heart disease ranks first abroad. cerebrovascular disease; Heart disease; respiratory diseases; injuries and poisoning; digestive disorders; endocrine nutrient metabolism and anti-emaciation; urinary and reproductive diseases; Mentally ill; Neuropathy. The diseases occupied by the rural occupancy are respiratory diseases, followed by cerebrovascular diseases; Malignancy; injuries and poisoning, heart disease; Tuberculosis, which is not ranked in the top 10 in the national statistics, ranks ninth in rural areas. Ranked by the World Health Organization as heart disease; Cancer; Stroke; Diabetes. It can be seen that cardiovascular and cerebrovascular diseases, diabetes and other diseases have prominently threatened the health of our people. At present, there are more than 40,000 hypertension patients in China alone, and there are 10,000 new people every year. Diabetes is known as the "third killer of society" in the world, second only to coronary heart disease and malignant tumors, and now has a blade in China. More than 10,000 patients, and the number of new patients is 10,000 every year. These changes will not only affect the exhibition of medicine itself, but also affect the structure and total market volume of related Chinese and Western drugs and medical device products

Xiao Zhen heard such a detailed explanation of the relationship between population and disease structure and distribution for the first time, so he looked towards Su Ning, but saw that Su Ning was calm, and couldn't help nodding secretly in his heart, it seemed that Su Ning had an understanding of this, so he looked down on her. Thinking about it, this layman is just one or two decades more knowledgeable than her, and he knows the general direction of the future exhibition, but when it comes to these details, how can he compare with a person like her who specializes in this way every day? Now that she knows, she must have some layout, right? Well, that's not much to worry about.

Zheng Denggao continued: "Another point is that there is a clear linear relationship between population growth and increased mobility in economic areas and the consumption of pharmaceuticals.

Since the reform and opening up, the pharmaceutical economy in Lingnan, Jiangdong and other provinces has continued to grow at a high rate for many years. In terms of administrative management, China implements a hierarchical system of medical and health institutions, and hospitals at different levels and levels have different technical standards and equipment requirements. This management system once stimulated the activity of the domestic medical device market, and many hospitals tried to purchase large-scale medical equipment in order to upgrade and upgrade. In February this year, the old document of the Government Council "Guiding Opinions on the Reform of the Urban Medical and Health System, the reform of the small health system is its main content, and the main points of the reform of the health system are the implementation of industry-wide management of health work; The second is to strengthen the macro management of health resources, divide medical institutions into non-profit and for-profit hospitals, establish a new classification management system for medical institutions, and implement the "separate accounting" of medicine, and change the hospital outpatient pharmacy into a drug retail enterprise on the basis of shaking the financial subsidy method and adjusting the price of medical services. However, the second model is the purchase and sale of drugs. The change in policy will have a significant impact on the change of the structure of the pharmaceutical market. According to my analysis, the demand for general medicine and conventional medical technology equipment with low cost, low maintenance cost, high clinical value and wide application coverage will increase, especially products and medical technology that can shorten the hospital stay will be very popular. ”

Xiao Ding subconsciously looked at Su Ning again, this time Su Ning showed a solemn expression, it seems that this document in February, Tianxin has not had time to study it carefully. In addition, Xiao Zhen guessed that she was also concerned about another matter, which was only after Xiao Zhen told her, and she began to think about it, that is, Xiao Ke hoped that Tianxin Group would get another hospital department and intervene in the hospital market. It's just that in China, hospitals are not as good as others, which are quite strictly restricted, and Su Ning's understanding of this is not too high, so Zheng Denggao mentioned that "the pharmacy is separated." , I listened quite seriously. Xiao Ding thought about it, nodded, and said with a smile: "I'll take a closer look at this matter later, please continue." ”

Liu Mingquan glanced at Zheng Denggao, but Zheng Denggao smiled and waved his hand, signaling him to continue, seeing what it meant, he planned to mainly give Liu Mingquan a supplementary explanation.

Liu Mingquan smiled and continued: "In the new century, pharmaceutical retail chains have become an inevitable trend. In recent years, with the reform of the pharmaceutical supporting system, China's pharmaceutical retail chain has shown a rapid development momentum. Not long ago, the State Food and Drug Administration issued the "Measures for the Management of Pharmaceutical Retail Chains Across Provincial and Municipal Chains", and the second batch of Tianjia Pharmaceutical Retail Cross-Provincial Chain Pilot Enterprises. It provides an opportunity for the formation of a large-scale, standardized and intensive pharmaceutical retail chain. It should be noted that China's pharmaceutical retail chain is in the early stage of development, lack of standardization, market concentration and market share is not high. To this end, enterprises should make use of the existing advantages of products, manpower, warehousing and transportation to develop distribution centers, not only for their own distribution, but also for retail stores and retail chain enterprises to optimize resource allocation. At the same time, in accordance with the requirements of the modern enterprise system, the retail chain enterprises will be transformed into a corporate system, and a new type of retail chain operation enterprises will be established that operate independently, bear their own profits and losses, pay taxes according to regulations, and assume the responsibility of maintaining the value of the owner's net asset value. It can be formed as a sole proprietorship, a joint venture, or through holding, equity participation, merger, or joint formation; It can be operated cooperatively across regions, provinces and cities, across borders, across industries, across departments and across ownership; It can also be used as the center store in the central city to carry out franchising, so as to wave the advantages of scale, information, management, and service

Speaking of this, the smile on his face became even bigger, and he looked at Su Ning: "Su Dong's Tianxin Pharmaceutical Group is the largest group in our Huaxia pharmaceutical industry, I think Tianxin should have the ability to do this by itself, right?" ”

Su Ning's heart moved, Tianxin is not as good as state-owned enterprises, many pharmaceutical state-owned enterprises seem to have very high sales revenue, such as Oriental Pharmaceutical Group, Sanjiu Group, Huaxia Pharmaceutical Group, Linjing Pharmaceutical Group, etc., all of which are not tens of billions or billions of sales revenue, which seems to be not much lower than Tianxin, and Oriental Pharmaceutical Group is even quite close to Tianxin Pharmaceutical Group's sales revenue, but that is only a superficial phenomenon. In fact, the final profit of Oriental Medicine Group is only 800 million, not even 300 million! In addition to Tianxin Pharmaceutical Group, the first place in the profit list of pharmaceutical companies is Linjing Pharmaceutical Group, with a profit of 700 million; followed by the Sanjiu Group, which hurt 100 million.

The profits of these two seem to be a lot, but if you compare them with Tianxin, it will be really too bad! What was Tianxin Group's total profit last year? Wind and mortar! It's just one kick away from breaking the 2 billion mark! It can almost be said that the profits of the country's top pharmaceutical groups are added up to the profits of Tianxin. The annual profit of Tianxin is equal to one-sixth of the annual profit of the national pharmaceutical industry!

Such a strong and powerful Tianxin Pharmaceutical Group, if it doesn't do this, who will? Tianxin should have the ambition of "pharmaceutical retail chain, who else can I be" at this moment!

Su Ning thanked Liu Mingquan with a straight face: "Director Liu, these words are really the guiding light of Tianxin, but it's a pity that there is no wine, otherwise Su Ning should really give you a glass." She smiled and picked up the coffee cup: "People use tea instead of wine, but I don't even have tea, so I have to replace wine with coffee, thank you Director Liu for pointing her to her, and I drank that cup of coffee."

Liu Mingquan said politely: "Su Dong is polite, since this is the case, I don't dare not drink it, and I also drank the cup of coffee that was still a little hot." Although the coffee is a little hot, his heart is even hotter, with Su Ning's attention, Xiao Shao must be able to add to himself. Thinking about this. The mood suddenly improved.

However, he will not forget that there is also a Zheng Denggao by his side, there must be competition between him and Zheng Denggao, which is needless to say, but at the same time, they must also join hands, only if the two are consistent, Xiao Shao will be satisfied, after all, Xiao Shao has already explained one thing when he came to them today, that is, both of them are Xiao Shao's favor. Since this is the case, Xiao Zhen definitely doesn't want anything rough and small between the two of them, or rather, the person behind Xiao Zhen doesn't want it. But the meaning is the same, the Xiao family will not want people who are not good at the unity within the two people to enter their circle.

Therefore, although Liu Mingquan was secretly excited, he still modestly said to Zheng Deng: "Does Lao Zheng want to add?" ”

Willing to add something for Zheng Denggao, so as not to be beloved by him before Xiao Zhen, but Zheng Denggao smiled this time: "I didn't add this one." ”

Liu Mingquan was a little strange, but Zheng Denggao said: "I'll say the next one, and then I said before: "As I said earlier, the relevant departments of the state are studying the reform plan for the disadvantages of the joint pharmaceutical industry, and the general idea is to separate medical treatment and pharmaceutical operations, that is, to separate medicine and medicine. The old document of the Government Council has made it clear that medicine should be separated, and the first step is to "separate accounting and separate management" of medicine revenue and expenditure. If the division of medicine is really realized in the future, we will be able to put an end to the phenomenon of doctors being motivated by interests to prescribe large amounts of expensive drugs, and we will really prescribe the right medicine according to the condition, and then some valuable drugs may be partially replaced by cheap and effective general drugs, and the growth rate of some ordinary drugs will be moderate. The real division of the pharmaceutical industry will reduce the number of hospitals in large and medium-sized cities in China by one-third. And the current relative medical resources will be transferred to small and medium-sized cities and rural areas. The reduction of medical resource waste means a decrease in drug consumption, and it is estimated that the cutting % of pharmaceutical companies will fade out of the industry. The competition between pharmaceutical companies is often brutal. If you are not fully sure. I believe that forward-thinking entrepreneurs should gradually withdraw from the market for traditional medicine products in general. ”

When he said this, he didn't look at Su, but just stated his opinion as if it was an ordinary discussion. But this demeanor made Xiao Zhen more satisfied, this Zheng Denggao is indeed very smart.

Xiao is in the system, so he naturally knows the affairs of Huaxia best. Once the pharmaceutical division is implemented, the wave of mergers between pharmaceutical commercial enterprises will surge, the mergers between industry and commerce will also be extremely intense, and the pharmaceutical retail industry will flourish; The upgrading of Huaxia's pharmaceutical industry has become possible, and some listed companies with pharmaceutical as their main business have monopolized part of the market and become a group with transnational competitiveness; Even the pharmaceutical market in China may be clear and Haiyan, and the pharmaceutical management will truly move towards the track of legalization.

Zheng Denggao seemed to be admonishing, and seemed to be saying that it was better to withdraw from some markets, but in fact, Xiao Zhen naturally understood that he was just saying this on purpose. In fact, what he really means is: Tianxin Pharmaceutical Group can take this opportunity to swallow up some companies that want to withdraw from this type of market, of course, if you don't like it, you can also squeeze out and seize the market gap left by them, so as to strengthen the market dominance of Tianxin Pharmaceutical Group again. It's hard to say the most profitable industry in the world, but the most profitable system in the world must be a monopoly.

This is really a smart man. Xiao Ding affirmed again.

Liu Mingquan knew at a glance that Zheng Denggao's performance made Xiao Zhen very satisfied, there was cooperation and competition between him and Zheng Denggao, so naturally he couldn't weaken his own image, since Zheng Denggao continued to peddle his method with Xiao Zhen and Su Ning that seemed to be a bit like exploiting the loopholes of the system, then he had to continue to explain his method just now in more depth. You Zheng Denggao can let Tianxin further expand its market share, naturally it is your ability, but I Liu Mingquan is not bad, if I follow my method, Tianxin can also dominate the national pharmaceutical retail industry, and the profit in it is not necessarily smaller than yours!

Liu Mingquan continued: "China has implemented the O-system from January 1 in Wodong. After the implementation of classification management, the production of non-prescription drugs enterprises may be differentiated to a faster degree, some of which are of good product quality, wide range of objects, strong economic strength of enterprises, increase efforts to promote their products with their own proprietary trademark brands, expand the market, the formation of famous brand advantages, enterprises correspondingly grow exhibition, rely on non-prescription drugs to quickly develop.

In addition, as Lao Zheng just said, there are quite a lot of small and weak small and medium-sized enterprises, although they also produce over-the-counter drugs, but the economic strength of hard work is weak, the publicity is low, or there is no money to advertise, can only squeeze out their original market for brand-name products, and even make some enterprises disappear from the pharmaceutical industry

He shrugged his shoulders with some American flavor and continued: "After the classification and management of drugs, the concentration of the production of non-prescription drugs has gradually increased, driven by the interests of operating non-prescription drugs, there will be some enterprises and research units to develop more safe and effective, low-cost drugs are active, expand the non-prescription drug market, benefit the society, the rise of the drug market, bring gratifying prospects to China's drug sales, and at the same time put forward requirements for the pharmaceutical business, especially retail enterprises, to improve the level of operation and service." It can be safely foreseen that due to the huge market and government policy support, it will make. What the market cultivates is a famous brand. The strengthening of the trademark identification system and the growth of it into a well-known trademark will be an important brand for China's pharmaceutical companies to occupy the billion-dollar market, which can be the specialty of Tianxin Pharmaceutical Group, and in this regard, Tianxin Pharmaceutical Group has a huge advantage. ”

Xiao Ding, Su Ning and Zheng Denggao on the side all smiled slightly, this is true, Tianxin's main products are almost all famous brands, Tianxin's ability to build famous brands, in today's Chinese pharmaceutical industry, it claims to be the second, and no one dares to call it the first. Because, the word "Tianxin Medicine" is already one of the largest famous brands, with the habits of the Chinese people, they have always believed that large enterprises and big brands, Tianxin is the overlord of medicine, and the degree of trust of the Chinese people in it is naturally needless to say.

Liu Mingquan smiled with him, and then continued: "At present, medical and health institutions and the growing material and cultural living standards of the people objectively require the pharmaceutical industry to provide high-quality pharmaceutical products, and the international circulation of pharmaceutical products also requires that they must meet international standards. This is an invisible pressure on the implementation of pharmaceutical enterprises in China. Under the guidance of certain laws and policies, it is in the interests of the majority of people to adopt enforcement measures. If it is not enforced, once WTO accession becomes a fact and the drug tax rate is further reduced, China's huge preparation production system is bound to face the danger of being destroyed by multinational corporations, and a number of pharmaceutical companies may be merged or eliminated. If it is enforced, the state must formulate corresponding regulations and standardize the implementation. The division of pharmaceutical industry and the price of drugs must be reformed simultaneously, and the scale of preparation production in medical institutions must be restricted or banned, so as to implement real fair competition. The growth and expansion of China's pharmaceutical industry has become possible, and the rational investment in the pharmaceutical industry will be valued. Mandatory implementation, without the introduction of supporting regulations and policies, pharmaceutical companies will inevitably die. This is the current situation that some enterprises take the initiative to describe as early transformation and early death, and wait for death if they do not reform, and a large number of existing enterprises will be eliminated, which is a good way to adjust the structure of pharmaceutical enterprises.

This is the attitude of the superior, he is not a person in the pharmaceutical industry, but a person who manages them, and naturally has the ease and chic of sitting and watching the clouds disappear.

"Since implementation is a matter of time, as a visionary entrepreneur, we must call on the government to take integrated measures to promote it on the one hand, and plan ahead on the other. First, the variety, the added value must be high, to have characteristics and competitiveness, and it is best to have a market share of more than 100%; the second is talents, technical talents and management talents; the third is the observation of national laws and regulations, which affects the value orientation of national laws and regulations makers from many aspects; Fourth, if it is implemented at present, it must adopt international advanced standards, in order to smoothly integrate with Liu Mingquan in the future.

Xiao Zhen nodded, and suddenly said, "My uncle is resting at home today, if you two have it."

Liu Mingquan and Zheng Denggao's hearts jumped at the same time, and their eyes couldn't help but become hot anymore!

Abandon Shock smiled.

After all, these are two available talents.